|
Volumn 17, Issue 8, 2000, Pages 911-919
|
An economic cost analysis of oral ganciclovir prophylaxis for the prevention of CMV disease
|
Author keywords
AIDS; Cost; Cytomegalovirus; Ganciclovir; Pharmacoeconomics; Sample selection bias
|
Indexed keywords
GANCICLOVIR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST OF ILLNESS;
CYTOMEGALOVIRUS INFECTION;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFICACY;
HOSPITAL COST;
HUMAN;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ALGORITHMS;
AMBULATORY CARE;
ANTIVIRAL AGENTS;
CAREGIVERS;
CYTOMEGALOVIRUS INFECTIONS;
DOUBLE-BLIND METHOD;
GANCICLOVIR;
HEALTH RESOURCES;
HOSPITAL COSTS;
HUMANS;
|
EID: 0033804944
PISSN: 07248741
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1007562818091 Document Type: Article |
Times cited : (2)
|
References (15)
|